Education
About Us
Working with TipRanks
Follow Us
BetterLife Pharma (TSE:BETR)
:BETR
BETR Stock Chart & Stats
C$0.05
C$0.01(9.52%)
At close: 4:00 PM EST
C$0.05
C$0.01(9.52%)
Day’s Range― - ―
52-Week RangeC$0.05 - C$0.18
Previous CloseN/A
Volume50.00
Average Volume (3M)121.96K
Market Cap
$8.35M
Enterprise ValueC$17.40M
Total Cash (Recent Filing)$19.00K
Total Debt (Recent Filing)$1.30M
Price to Earnings (P/E)―
Beta-0.08
Next Earnings
Dec 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding151,838,730
10 Day Avg. Volume118,740
30 Day Avg. Volume121,961
Financial Highlights & Ratios
PEG Ratio-0.60
Price to Book (P/B)-1.51
Price to Sales (P/S)0.00
P/FCF Ratio-7.96
Enterprise Value/Market Cap2.08
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-23.78
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BetterLife Pharma News
BETR FAQ
What was BetterLife Pharma’s price range in the past 12 months?
BetterLife Pharma lowest stock price was C$0.04 and its highest was C$0.17 in the past 12 months.
What is BetterLife Pharma’s market cap?
BetterLife Pharma’s market cap is $8.35M.
When is BetterLife Pharma’s upcoming earnings report date?
BetterLife Pharma’s upcoming earnings report date is Dec 19, 2025 which is in 6 days.
How were BetterLife Pharma’s earnings last quarter?
BetterLife Pharma released its earnings results on Sep 26, 2025. The company reported -C$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.003.
Is BetterLife Pharma overvalued?
According to Wall Street analysts BetterLife Pharma’s price is currently Overvalued.
Does BetterLife Pharma pay dividends?
BetterLife Pharma does not currently pay dividends.
What is BetterLife Pharma’s EPS estimate?
BetterLife Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BetterLife Pharma have?
BetterLife Pharma has 151,838,730 shares outstanding.
What happened to BetterLife Pharma’s price movement after its last earnings report?
BetterLife Pharma reported an EPS of -C$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of BetterLife Pharma?
Currently, no hedge funds are holding shares in TSE:BETR
Company Description
BetterLife Pharma
BetterLife Pharma Inc. is a biotechnology company engaged in the development and commercialization of therapeutic products for mental health disorders. The company operates in the healthcare sector, focusing on the research and development of novel compounds for the treatment of depression, anxiety, and other neurological conditions. BetterLife Pharma's core products include psychedelic-based therapies and treatments designed to improve mental health outcomes.
Technical Analysis
Options Prices
Currently, No data available
---